← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 17, 2020Last known activity
Jul 15, 2025
Timeline
2010s
- Jun 1, 2018
Aligos Therapeutics— Founded
Drugs by trial phase (12 distinct, 13 trials)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT06963710Lead sponsorPhase 2Jul 15, 2025
- NCT06959888Lead sponsorPhase 1Mar 25, 2025
- NCT06698549Lead sponsorPhase 1Jan 31, 2025
- NCT06672900Lead sponsorPhase 1Jan 9, 2025
- NCT06568861Lead sponsorPhase 1Sep 30, 2024
- NCT06342947Lead sponsorPhase 2Apr 1, 2024
- NCT06191991Lead sponsorPhase 1Nov 3, 2023
- NCT05840952Lead sponsorPhase 1Jul 4, 2023
- NCT05561530Lead sponsorPhase 1Oct 7, 2022
- NCT05090111Lead sponsorPhase 1Nov 30, 2021
- NCT05001022Lead sponsorPhase 1Sep 29, 2021
- NCT04536337Lead sponsorPhase 1Oct 22, 2020
- NCT04485663Lead sponsorPhase 1Aug 17, 2020
Details
- Founded
- South San Francisco, CA, US Jun 1, 2018
- Last known activity
- Jul 15, 2025